Immunocore Holdings plc (NASDAQ:IMCR) Q4 2022 Earnings Call Transcript
Operator: Greetings. Welcome to the Immunocore 2022 Financial Results and Business Update Call. Please note, this conference is being recorded.
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings. Welcome to the Immunocore 2022 Financial Results and Business Update Call. Please note, this conference is being recorded.
Operator: Welcome to Amarin Corporation's Conference Call to Discuss its Fourth Quarter and Full Year 2022 Financial Results and Operational Update.
Operator: Good morning ladies and gentlemen and welcome to Cerevel Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. Please note that this call may be recorded.
AMRN earnings call for the period ending December 31, 2022.
Moderna Inc. on Thursday forecast declining COVID-19 vaccine sales and rising costs for 2023, raising concerns the U.S. ...